- Become a partner
- Title Partners
- General Partners
- Networking Area Partners
- Business Programme Partners
- Governors’ Club Partners
- Innovation Space Partners
- “Arctic: Territory of Dialogue” Area Partners
- VinoGrad Space Partners
- Business Priority Partners
- Official Suppliers of the Forum
- Cultural Programme Partners
- Sports and Entertainment Programme Partners
- Media Partners
- Roscongress Club Partners
- Healthy Life Project Partners
- The Drug Security Forum Partners
- SPIEF Junior Forum Partners
- Creative Business Forum Partner
The Federal Medical-Biological Agency (FMBA of Russia) is a federal executive authority that ensures the radiation, chemical, and biological safety of the country and the population, as well as assures a health protection system at enterprises of strategically important industries with particularly dangerous working conditions.
The Federal Medical and Biological Agency serves about 3.5 million people living in 20 closed administrative territorial entities, 39 satellite cities, and science cities (in Russian, naukograd) located in 54 subjects of Russia and the city of Baikonur in Kazakhstan. The FMBA of Russia includes more than 300 subordinate medical organizations and about 2,500 health facilities in Russia and Baikonur.
Veronika Skvortsova - Head of the Federal Medical-Biological Agency
The Autonomous Non-Profit Organization Center for Strategic Initiatives of FMBA was formed under the aegis of the Federal Medical Biological agency in 2021. The Center is engaged in distribution and promotion of innovation tehnology and pharmaceutical products developed by the network of institutions of the FMBA of Russia.
Full-scale campaign of Center for Strategic Initiatives of FMBA is aimed to optimizing and modernizing processes in the healthcare area and medical tehnology, in particular to implementing healthcare digitalization projects.
Nikita Odintsov - Director of the Center for Strategic Initiatives of FMBA
Petrovax is a Russian full-cycle biopharmaceutical company with 25 years of successful experience. The company is a part of the Interros Group.
The product portfolio includes its original pharmaceutical products and vaccines, generics and food supplements. The company has its own research center. Petrovax holds new molecule and manufacturing process international patents. The company's production operates in full compliance with international GMP. A modern pharmaceutical production complex located in the Moscow region is one of the most high-tech biopharmaceutical facilities in Russia.
Petrovax is the largest Russian exporter of original medicinal products. The company exports products to 12 countries, including the EAEU, the Middle East and the EU. Petrovax's partners are the world's leading pharmaceutical companies Pfizer, Abbott, Boehringer Ingelheim, CanSino Biologics Inc.
Petrovax’s investment strategy aims at the R&D, development of manufacturing and import substitution of drugs and vaccines used in socially significant areas of medicine, such as oncological, autoimmune, infectious and orphan diseases.
Mikhail Tsyferov - President, Member of the Board of Directors, NPO Petrovax Pharm LLC (part of the Interros Group) Managing Director, Winter Capital Fund Private investor in several healthtech, edutech and fintech projects
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
Marek Vasicek - General Manager Bristol-Myers Squibb Russia
CJSC Evalar is one of the largest pharmaceutical manufactures in Biysk city, Altai Territory, Russia and it is the national leader in dietary supplements. They produce around 500 of various products starting from diatary and food supplements to medicine.
Evalar was the first company to implement a full production cycle - from growing plants to packaging finished products. The company takes quality and safety very seriously and complies to the following standards: ISO 9001:2015, ISO 22000 (HACCP), as well as GMP.
Evalar opened a second manufacturing facility for medicine production in 2019, which increased the production capacity by one and a half times.
Evalar was recognised by the international research company Euromonitor International as a leader in terms of sales of multicomponent dietary supplements in Eastern Europe, Russia and the CIS countries.
The company celebrated its 30th anniversary in December 2021.
Natalia Prokopieva - Evalar's Chairwoman of the Board of Directors
MyGenetics has been generating personal recommendations aimed to maintain health based on DNA analysis since 2013.
Genetic researches are involved in vital health solutions: personal diet rations, comfortable weight maintenance, skin procedures, sport exercises, detoxification system, stress and anxiety reduction, vitamins correct forms and dosages etc.
Genetic scientists, molecular biologists and medical practitioners are working on DNA report recommendations.
Personal report is designed as a glossy magazine, printed version on demand. MyGenetics DNA tests include an online consultation with company experts who assist to understand the report details, adjust lifestyle and answer all questions.
MyGenetics services are used by both private clients and medical centers, clinics, medical practitioners, nutritionists, fitness centers and wellbeing-companies.
Vladimir Volobuev - Director of MyGenetics, techpreneur
Skolkovo is the biggest innovation center in Russia. It plays a prominent role in strengthening the foundation of the national economy. Startups promoted by Skolkovo offer domestic hi-tech products for industrial applications, health care, transport industry, IT and many other industries. Skolkovo ecosystem is a suite of specialized customer-centered services and relevant support measures for innovative industries: from acceleration and support of private investors and university-based startups, to overseas patenting and customs clearance. Skolkovo Technopark is the largest industrial park in Eastern Europe. Skoltech, Skolkovo’s ‘science core’, in 2021 was among the best young universities worldwide, according to Nature Index. In 2021, the total revenues of Skolkovo residents grew almost by 55%, as compared with 2020, reaching RUB 247.8 billion. As of May 1, 2022 the number of Skolkovo startups exceeded 3,300. The number of jobs within the ecosystem is about to reach 70,000.
Igor Drozdov - Chairman of the Board, Skolkovo Foundation
ZAO Medical and Preventive Care Institution of Natural Health Improvement “Klinika Kivach” is a long-time leader in the health resort field in Russia that focuses on body cleanse and natural health improvement. It is a frequent winner of Russian and European awards in the “Best Detox Clinic”, “Best Anti-Age Clinic” categories, one of the leaders of the “Top 100 of Russian Health Resorts” rating, as well as received the Recognized by EFQM 5 Star certificate.
Kivach Clinic is a multi-disciplinary medical facility. Through its 25 years of experience it has acquired vast experience and knowledge and developed unique methods that help treat chronic diseases through body cleanse.
Aleksandra Ulich - CEO of ZAO Medical and Preventive Care Institution of Natural Health Improvement “Klinika Kivach”